On the other hand, it is conceivable that cellular ATP levels may modulate ALDH1A3 activity by a negative feedback mechanism, similarly to some enzymes participating in the glycolytic pathway, which may be relevant in other disease states such as obesity and diabetes. Here, ALDH1A3 is linked to obesity due to melanocortin 4 receptor deficiency.